TransMedics Shares Surge Following Strong Q3 Earnings and Upgraded Long-Term Outlook
TransMedics (TMDX) shares experienced a significant rally, climbing over 25% in intraday trading following the release of third-quarter financial results that exceeded analyst expectations. This surge marks the company's strongest single-day performance since November 2023. The positive market reaction was driven by a 'solid Q3 print' and management's decision to raise its financial outlook through 2026. The improved guidance suggests strong momentum for the organ care provider as it continues to scale its operations.
Tickers: $TMDX